Comprehensive Care Models for Cardiometabolic Disease

[1]  R. Eckel,et al.  Cardiometabolic Medicine: Development of a New Subspecialty. , 2020, The Journal of clinical endocrinology and metabolism.

[2]  G. De Backer,et al.  Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery Disease—A Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE V , 2020, Diabetes Care.

[3]  Jessica L. Barrett,et al.  Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity. , 2019, The New England journal of medicine.

[4]  Akshay S. Desai,et al.  Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. , 2019, The New England journal of medicine.

[5]  Deepak L. Bhatt,et al.  Use of Guideline-Recommended Risk-Reduction Strategies Among Patients with Diabetes and Atherosclerotic Cardiovascular Disease: Insights from Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD). , 2019, Circulation.

[6]  S. Fazio,et al.  The Role of the Clinical Pharmacist in a Preventive Cardiology Practice , 2019, The Annals of pharmacotherapy.

[7]  W. E. Sanabria,et al.  Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial , 2019, The Lancet.

[8]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association , 2019, Circulation.

[9]  J. King,et al.  Medicare Annual Wellness Visit association with healthcare quality and costs. , 2019, The American journal of managed care.

[10]  R. Califf,et al.  Call to Action: Urgent Challenges in Cardiovascular Disease A Presidential Advisory From the American Heart Association , 2019, Circulation.

[11]  C. Cannon,et al.  Composite cardiovascular risk factor target achievement and its predictors in US adults with diabetes: The Diabetes Collaborative Registry , 2019, Diabetes, obesity & metabolism.

[12]  M. Hernán,et al.  Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra‐Virgin Olive Oil or Nuts , 2018, The New England journal of medicine.

[13]  Craig M. Hales,et al.  Trends in Obesity and Severe Obesity Prevalence in US Youth and Adults by Sex and Age, 2007-2008 to 2015-2016 , 2018, JAMA.

[14]  Michael E. Thompson,et al.  The effect of North Carolina free clinics on hospitalizations for ambulatory care sensitive conditions among the uninsured , 2018, BMC Health Services Research.

[15]  R. Guthrie.  Canagliflozin and cardiovascular and renal events in type 2 diabetes , 2018, Postgraduate medicine.

[16]  Alison B. Evert,et al.  Academy of Nutrition and Dietetics Nutrition Practice Guideline for Type 1 and Type 2 Diabetes in Adults: Systematic Review of Evidence for Medical Nutrition Therapy Effectiveness and Recommendations for Integration into the Nutrition Care Process. , 2017, Journal of the Academy of Nutrition and Dietetics.

[17]  M. Fornage,et al.  Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.

[18]  Xiaoqin He,et al.  Diabetes self-management education reduces risk of all-cause mortality in type 2 diabetes patients: a systematic review and meta-analysis , 2017, Endocrine.

[19]  R. Hamman,et al.  Association of Type 1 Diabetes vs Type 2 Diabetes Diagnosed During Childhood and Adolescence With Complications During Teenage Years and Young Adulthood , 2017, JAMA.

[20]  S. Potthoff,et al.  Multidisciplinary Approach in the Treatment of Resistant Hypertension , 2017, Current Hypertension Reports.

[21]  K. Nasir,et al.  Comparative effectiveness of outpatient cardiovascular disease and diabetes care delivery between advanced practice providers and physician providers in primary care: Implications for care under the Affordable Care Act. , 2016, American heart journal.

[22]  Lawrence H. Kushi,et al.  Recent Trends in Cardiovascular Mortality in the United States and Public Health Goals. , 2016, JAMA cardiology.

[23]  W. Garvey,et al.  Trends in Cardiovascular Health Metrics in Obese Adults: National Health and Nutrition Examination Survey (NHANES), 1988–2014 , 2016, Journal of the American Heart Association.

[24]  M. Fischereder,et al.  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. , 2016, The New England journal of medicine.

[25]  Linnea A. Polgreen,et al.  Cost-Effectiveness of a Physician–Pharmacist Collaboration Intervention to Improve Blood Pressure Control , 2015, Hypertension.

[26]  Dave L Dixon,et al.  The CardioMetabolic Health Alliance: Working Toward a New Care Model for the Metabolic Syndrome. , 2015, Journal of the American College of Cardiology.

[27]  G. Targher,et al.  Understanding the association between developing a fatty liver and subsequent cardio-metabolic complications , 2015, Expert review of gastroenterology & hepatology.

[28]  J. Bryant,et al.  A systematic review of barriers to optimal outpatient specialist services for individuals with prevalent chronic diseases: what are the unique and common barriers experienced by patients in high income countries? , 2015, International Journal for Equity in Health.

[29]  L. Strawbridge,et al.  Use of Medicare’s Diabetes Self-Management Training Benefit , 2015, Health education & behavior : the official publication of the Society for Public Health Education.

[30]  S. Shrestha,et al.  Diabetes Self-Management Education and Training Among Privately Insured Persons with Newly Diagnosed Diabetes — United States, 2011–2012 , 2014, MMWR. Morbidity and mortality weekly report.

[31]  D. Berwick,et al.  Graduate Medical Education That Meets the Nation's Health Needs , 2014 .

[32]  B. Zinman,et al.  Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. , 2014, Circulation.

[33]  W. Polonsky,et al.  The confusing tale of depression and distress in patients with diabetes: a call for greater clarity and precision , 2014, Diabetic medicine : a journal of the British Diabetic Association.

[34]  T. Wadden,et al.  Reprint: 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk. , 2014, Journal of the American Pharmacists Association : JAPhA.

[35]  Dolores Corella,et al.  Primary prevention of cardiovascular disease with a Mediterranean diet. , 2013, The New England journal of medicine.

[36]  R. Bond,et al.  Structured Type 1 Diabetes Education Delivered Within Routine Care , 2013, Diabetes Care.

[37]  M. Woodward,et al.  Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis , 2012, The Lancet.

[38]  D. Wald,et al.  Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. , 2012, The American journal of medicine.

[39]  C. Fryar,et al.  Prevalence of uncontrolled risk factors for cardiovascular disease: United States, 1999-2010. , 2012, NCHS data brief.

[40]  A. Wang,et al.  Serum small-dense LDL abnormalities in chronic renal disease patients , 2012, British journal of biomedical science.

[41]  C. Clar,et al.  Glucagon-like peptide analogues for type 2 diabetes mellitus. , 2011, The Cochrane database of systematic reviews.

[42]  Rory Wolfe,et al.  The number of years lived with obesity and the risk of all-cause and cause-specific mortality. , 2011, International journal of epidemiology.

[43]  J. Danesh,et al.  Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies , 2010, The Lancet.

[44]  V. Basevi.  Standards of Medical Care in Diabetes—2010 , 2010, Diabetes Care.

[45]  Shimin Zheng,et al.  The potency of team-based care interventions for hypertension: a meta-analysis. , 2009, Archives of internal medicine.

[46]  Lawrence J. Fine,et al.  ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Compete , 2009, Circulation.

[47]  P Michael Ho,et al.  Medication Adherence: Its Importance in Cardiovascular Outcomes , 2009, Circulation.

[48]  H. J. Jiang,et al.  Nationwide Frequency and Costs of Potentially Preventable Hospitalizations, 2006 , 2009 .

[49]  F. Lobelo,et al.  Physical activity habits of doctors and medical students influence their counselling practices , 2008, British Journal of Sports Medicine.

[50]  C. Schoen,et al.  In chronic condition: experiences of patients with complex health care needs, in eight countries, 2008. , 2008, Health affairs.

[51]  B. Astor,et al.  Mild elevations of urine albumin excretion are associated with atherogenic lipoprotein abnormalities in the Multi-Ethnic Study of Atherosclerosis (MESA). , 2008, Atherosclerosis.

[52]  Sharon-Lise T Normand,et al.  Use of Cardiac Rehabilitation by Medicare Beneficiaries After Myocardial Infarction or Coronary Bypass Surgery , 2007, Circulation.

[53]  H. McRobbie,et al.  Effectiveness of specialist group treatment for smoking cessation vs. one-to-one treatment in primary care. , 2006, Addictive behaviors.

[54]  R. Eckel.  Preventive cardiology by lifestyle intervention: opportunity and/or challenge? Presidential address at the 2005 American Heart Association Scientific Sessions. , 2006, Circulation.

[55]  J. Gerberding,et al.  Actual causes of death in the United States, 2000. , 2004, JAMA.

[56]  Daniel Levy,et al.  Predictors of new-onset kidney disease in a community-based population. , 2004, JAMA.

[57]  I Campbell,et al.  Nicotine replacement therapy in smoking cessation. , 2003, Thorax.

[58]  C. Schmid,et al.  Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. , 2002, Diabetes care.

[59]  S. Yusuf,et al.  Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. , 2000, European heart journal.

[60]  A. Dyer,et al.  Diabetes, Asymptomatic Hyperglycemia, and 22-Year Mortality in Black and White Men: The Chicago Heart Association Detection Project in Industry Study , 1997, Diabetes Care.

[61]  P. Blackman.  Actual causes of death in the United States. , 1994, JAMA.

[62]  B. Winkelmann.  American Heart Association Scientific Sessions , 2004, Expert opinion on investigational drugs.

[63]  F. Porzsolt,et al.  Using machine learning to predict laboratory test results , 2016, Annals of clinical biochemistry.